¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"atomic chain"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
  • chain
    »ç½½, ¿¬¼â
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ(¼ú)
  • chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • food chain
    ¸ÔÀ̻罽
  • gamma chain disease
    °¨¸¶»ç½½º´
  • heavy chain
    ¹«°Å¿î»ç½½, Áß¼â
  • heavy-chain disease
    ¹«°Å¿î»ç½½º´, Á߼⺴
  • hemolytic chain
    ¿ëÇ÷»ç½½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • chain
    »ç½½
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ¼ú
  • chain fiber
    (¢¡nuclear chain fiber) Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain structure
    »ç½½±¸Á¶, ¿¬¼â±¸Á¶
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • closed chain
    ´ÝÈù»ç½½
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
  • food chain
    ¸ÔÀ̻罽
  • heavy chain
    ¹«°Å¿î»ç½½, Áß¼â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • heavy chain
    H¼â(¡­áð), Á߻罽.
  • heavy chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain disease
    H¼âº´(¡­áðÜ»), Á߼⺴(ñìáðÜ»).
  • heavy chain disease
    Áß ¼âº´
  • heavy-chain disease
    Á߼⺴
  • hemoglobin a,b-globin chain of
    ¥â-±Û·Îºó¼â(¡­áð)
  • hemolytic chain
    ¿ëÇ÷¿¬¼â.
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    Á¾ÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
  • polymerase chain reaction (PCR)
    ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction(PCR)
    ÁßÇÕ ¿¬¼â ¹ÝÀÀ
  • polymerase chain reaction=PCR
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • atomic explosion
    ¿øÀÚÆø¹ß.
  • atomic factor
    ¿øÀÚÀÎÀÚ(¡­ì×í­).
  • atomic fission
    ¿øÀںп­.
  • atomic group
    ¿øÀÚ´Ü.
  • atomic heat
    ¹æ»ç ¿øÀÚ¿­.
  • atomic hypothesis
    ¿øÀÚ°¡¼³(ê«í­Ê£æò).
  • atomic lattice
    ¿øÀÚ°ÝÀÚ(¡­Ì«í­).
  • atomic linkage
    ¿øÀÚ°áÇÕ(¡­Ì¿ùê).
  • atomic mass
    ¿øÀÚÁú·®(¡­òõåÖ).
  • atomic mass unit
    ¿øÀÚÁú·®´ÜÀ§
  • atomic model
    ¿øÀÚ¸ðÇü(¡­Ù¼úþ).
  • atomic nucleus
    ¿øÀÚÇÙ.
  • atomic number
    ¿øÀÚ¹øÈ£.
  • atomic number
    ¿øÀÚ¼ö, ¿øÀÚ¹øÈ£
  • atomic polarization
    ¿øÀںбØ(¡­ÝÂп), ¿øÀÚÆí±Ø(¡­ø¶Ð¿).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • carbon chain
    ź¼Ò(÷©áÈ) »ç½½
  • C-chain
    C»ç½½
  • chain
    »ç½½
  • chain conformation
    »ç½½ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • chain elongation
    »ç½½¿¬Àå(æÅíþ)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • chain initiation
    »ç½½Çü¼º(û¡à÷)°³½Ã(ËÒã·)
  • chain isomer
    »ç½½À̼ºÃ¼(ì¶àõô÷)
  • chain length
    »ç½½ ±æÀÌ
  • chain propagation
    »ç½½ Áõ½Ä(ñòãÖ)
  • chain reaction
    ¿¬¼â¹ÝÀÀ(ææáðÚãëë)
  • chain termination
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ)
  • chain termination codon
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) ÄÚµç
  • chain termination mutation
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) º¯ÀÌ(ܨì¶)
  • chain terminator
    »ç½½Çü¼º(û¡à÷) Á¾·áÀÚ(ðûÖõí­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
VL variable domain of the light chain; variable light chain
AA abdominal aorta; acetic acid; achievement age; active alcoholic; active assistive [range of motion];...
AAS Aarskog-Scott [syndrome]; acid aspiration syndrome; alcoholic abstinence syndrome; American Academy ...
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
ABCC Atomic Bomb Casualty Commission
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CVAAS Cold Vapour Atomic Absorption Spectrometry
ETAAS Electrothermal Atomic Absorption Spectrometry
GF-AAS Graphite furnace atomic absorption spectrometry
HG-AAS Hydride-generation atomic absorption spectrometry
ICP-AES Inductively Coupled Plasma Atomic Emission Spectrometry
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chain reflex
    ¿¬¼â ¹Ý»ç
    ÇϳªÀÇ Àڱؿ¡¼­ ´ÙÀ½ÀÇ ÀÚ±ØÀ¸·Î Â÷·Ê·Î ÀüÇØÁ®¼­ ¿ÏÀüÇÑ È°µ¿À¸·Î ³ªÅ¸³ª´Â ÀÏ·ÃÀÇ ¹Ý»ç.
  • chain structure
    ¿¬¼â ±¸Á¶
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • H chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain
    H »ç½½, H ¼â, Áß¼â
    1. ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ÇÑ ºÎºÐ. 2. ¸é¿ª ±Û·ÎºÒ¸°À» ±¸¼ºÇϰí ÀÖ´Â µÎ °³ÀÇ ºÐÀÚ¼âÀÇ ºÐÀÚ·®ÀÌ Å« Æú¸®ÆéŸÀ̵带 ¸»ÇÑ´Ù.
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
  • J chain
    J¼â, J »ç½½, ¿¬°á »ç½½
  • joining chain
    ¿¬°á »ç½½, ¿¬°á ¼â
  • L chain
    °æ¼â, °æ»ç½½, L¼â
  • lambda chain
    ¶÷´Ù »ç½½
  • lateral chain
    Ãø¼â
  • open chain compound
    ¿­¸° »ç½½ È­ÇÕ¹°
  • polymerase chain reaction
    ÁßÇÕ È¿¼Ò ¿¬¼â ¹ÝÀÀ
  • simple-chain peptide

    simplex (´Ü¼ø

CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
A chain A polypeptide component of insulin containing 21 amino acyl residues, beginning with a glycyl residue (NH2-terminus); insulin is formed by the linkage of an A chain to a B chain by two disulfide bonds; the amino-acid composition of the A chain is a function of species.
Synonym: glycyl chain.
In general, one of the polypeptides in a multiprotein complex.
(05 Mar 2000)
alpha chain disease A vague or indefinite term; could be used for alpha-heavy-chain disease (a lymphoplasma cell proliferative disease usually seen in Mediterranean men, characterised by intestinal involvement with steatorrhoea, often progressive with fatal outcome) or a thalassaemia (a genetic abnormality in the alpha globin chain of haemoglobin).
(05 Mar 2000)
amino acids, branched-chain Amino acids which have a branched carbon chain.
(12 Dec 1998)
B chain A polypeptide component of insulin containing 30 amino acyl residues, beginning with a phenylalanyl residue (NH2-terminus); insulin is formed by the linkage of a B chain to an A chain by two disulfide bonds; the amino-acid composition of the B chain is a function of species.
Synonym: phenylalanyl chain.
(05 Mar 2000)
behaviour chain Related behaviours in a series in which each response serves as a stimulus for the next response.
(05 Mar 2000)
branched chain acyl-CoA oxidase <enzyme> Enzyme from human liver peroxisomes acts on both 2-methyl branched fatty acyl- and bile acid-CoA intermediates, unlike rat liver peroxisomes which have separate enzymes for branched chain fatty acids (pristanoyl-CoA) and bile acid-CoA; involved in beta-oxidation of fatty acids and bil
Registry number: EC 1.3.3.-
Synonym: 2-methyl-branched chain acyl-CoA oxidase, hbrcacox
(26 Jun 1999)
branched-chain fatty-acid-kinase <enzyme> From anaerobic spirochete ma-2
Registry number: EC 2.7.2.14
Synonym: isovalerate kinase, 2-methylbutyrate kinase, isobutyrate kinase
(26 Jun 1999)
branched-chain fatty acid synthetase <enzyme> Analogous to fatty acid synthetase complex but starting with a branched chain keto acid; from bacillis subtilis
Registry number: EC 2.3.1.-
Synonym: bcfa synthetase
(26 Jun 1999)
branched chain ketoaciduria Hereditary disease due to deficiency of an enzyme involved in amino acid metabolism, characterised by urine that smells like maple syrup.
(12 Dec 1998)
branched chain ketonuria Hereditary disease due to deficiency of an enzyme involved in amino acid metabolism, characterised by urine that smells like maple syrup.
(12 Dec 1998)
gene rearrangement, alpha-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, beta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors.
(12 Dec 1998)
gene rearrangement, b-lymphocyte, heavy chain Ordered rearrangement of b-lymphocyte variable gene regions thereby contributing to antibody diversity. It occurs during the first stage of differentiation of the immature b-lymphocyte.
(12 Dec 1998)
gene rearrangement, b-lymphocyte, light chain Ordered rearrangement of b-lymphocyte variable gene regions coding for the kappa or lambda light chains, thereby contributing to antibody diversity. It occurs during the second stage of differentiation of the immature b-lymphocyte.
(12 Dec 1998)
gene rearrangement, delta-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • atomic energy
    ¿øÀÚ·Â Àü±â
  • atomic fissom
    ¿øÀÚÇÙ ºÐ¿­
  • atomic formula
    ¿øÀڽļ³
  • atomic fusion
    ¿øÀÚÇÙ À¶ÇÕ
  • atomic gun
    ¿øÀÚÆ÷
  • atomic mass
    ¿øÀÚ Áú·®
  • atomic number
    ¿øÀÚ ¹øÈ£
  • atomic pile
    ¿øÀÚ·Î(NUCLEAR REACTORÀÇ ±¸Äª)
  • atomic plant
    ¿øÀÚ·Â °øÀå
  • atomic power
    ¿øÀÚ·Â;¿øÀÚ·Â ¹ßÀü 
  • atomic power plant
    ¿øÀÚ·Â ¹ßÀü¼Ò 
  • atomic propulsion
    ¿øÀÚ·Â ÃßÁø
  • atomic reaction
    ¿øÇÙ ¹ÝÀÀ
  • atomic ship
    ¿øÀÚ·Â ÇÔ¼±
  • atomic submarine
    ¿øÀÚ·Â Àá¼öÇÔ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á